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Abstract- Gabapentin is popular analgesic adjuvants for improving postoperative pain management. The 
aim of this study was to compare the preventive effects of pre-emptive oxycodone and gabapentin on acute 
pain after elective abdominal hysterectomy. One hundred patients undergoing abdominal hysterectomy were 
randomly assigned to oxycodone group received 10 mg of oxycodone and gabapentin group received 10 mg 
of gabapentin 1 hour before surgery. The anesthetic technique was standardized, and the postoperative 
assessments included the amount of meperidine consumption, PONV and VAS for postoperative pain at 
arrival to recovery, 6, 12 and 24 h after surgery. Bleeding loss assessed during surgery. Postoperative pain 
scores were significantly lower in the gabapentin group compared with the oxycodone group. (P=0.0001) The 
total meperidine used in the gabapentin group was significantly less than in the oxycodone group. 
Postoperative nausea and vomiting (PONV) and blood loss during surgery were significantly decreased in 
gabapentin group. Based on the results of this study, Pre-emptive use of gabapentin 1200 mg orally, 
significantly decreases postoperative pain and PONV, rescues analgesic requirements and also bleeding loss 
during surgery in patients who undergo abdominal hysterectomy. Significant side effects were not observed.  
© 2018 Tehran University of Medical Sciences. All rights reserved.  
Acta Med Iran 2018;56(4):244-248. 
 
Keywords: Gabapentin; Pain relief; Oxycodone; PONV; Bleeding loss; Abdominal hysterectomy  
 
Introduction 
 
Early and late relief postoperative pain is an 
important challenge for anesthesiologists and surgeons. 
Thus, not only surgical procedures, preoperative 
interventions, need to be examined in clinical trials (1). 
Postoperative pain affects recovery from anesthesia and 
surgery (2). 
Prevention and treatment of postoperative pain and 
complications such as nausea and vomiting, keep being 
significant challenge in postoperative care and plays an 
important role in the early mobilization and well-being 
of the surgical patient. Given the plurality of 
mechanisms involved in postoperative pain, a 
multimodal analgesia regimen using a combination of 
opioid, non-opioid analgesics, and regional anesthesia 
has become the treatment of choice for simplifying the 
recovery period (3). 
Opioid analgesics, with their side-effects, likewise 
use in postoperative pain control; and testing new 
analgesics also combinations of analgesics in order to 
decrease the demand for opioids is a key region in acute 
pain research (4). 
Management of postoperative pain due to reducing 
suffering and due to earlier mobilization, shortened 
hospital stay, decreased hospital costs and raised 
patient’s satisfaction. Generally, the goal in all patients 
is to minimize exposure to the side effects of relatively 
high doses of systemic narcotics, while supplying 
sufficient analgesia (5-7). 
Gabapentin binds to the α2 δ subunit of voltage-
gated calcium channels, so preventing the release of 
nociceptive neurotransmitters including noradrenaline, 
substance P, and glutamate (8). 
Evidence offered that, in addition to being an 
effective analgesic for patients with chronic pain 
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syndromes or, neuropathic, gabapentin also provides 
effective postoperative analgesia when received before 
surgery (9-10). 
Gabapentin is an anticonvulsant that has been shown 
to be effective in the treatment of chronic pain and 
neuropathic (11-12). 
The analgesic effect of its perioperative use has not 
been entirely definite (9).  Hysterectomy is one of the 
most major gynecologic surgery (10) thus we designed 
the present study to investigate whether the pre-emptive 
use of gabapentin 900 mg orally could decrease 
postoperative pain, meperidine consumption and 
postoperative nausea and vomiting (PONV) during 24 h 
after hysterectomy.  
  
Materials and Methods 
 
In this double blinded randomized clinical trial, 
between 2013-2014, 100 patients who were candidate 
for abdominal hysterectomy in Rasoul Hospital, Tehran, 
Iran, was enrolled in the study. All ASA class I-II, 
patients that candidate for abdominal hysterectomy, 18-
60 aged, Consent to participate in the study enrolled in 
the study. Those without informed consent, Allergy to 
study drugs, History of drug abuse or alcohol 
dependence, Neuromuscular disease or a history of 
neurological or psychiatric, history of chronic pain 
syndromes excluded from the study.  
The study protocol was approved by ethics 
committee of Iran University of Medical Sciences, and 
the trial is registered at Iranian Registry of Clinical 
Trials, number IRCT139208011580N2. Each patient 
signed informed consent before enrollment in the study. 
The selected patients were randomly divided into two 
groups, oxycodone group (n=50) and gabapentin group 
(n=50), using block randomization in blocks containing 
four patients and non-blinded. The oxycodone group 
received oral oxycodone capsules 10 mg (Co: Razak-
Iran), and gabapentin group received oral gabapentin 
capsules 900 mg (Co: Razak-Iran) 1 hour before 
induction of anesthesia.  
For all the patients, the operation and anesthesia 
were performed by the same surgeon and anesthetist. 
After pre-oxygenation for 5 minutes, and access to IV 
line and under essential monitoring including automated 
non-invasive blood pressure monitoring (NIBP), the 
baseline hemodynamic parameters such as HR, systolic 
and diastolic blood pressure, and mean arterial pressure 
recorded using automated non-invasive blood pressure 
monitoring. 
All patients’ 0.01 mg/kg midazolam and 3 micro/kg 
fentanyl were administered preoperatively. 
Anesthesia induction performed in all patients in the 
same method, using Thiopental sodium (Thiopentone, 
Sandoz GmbH, Koundl, Astra) 4 mg/kg and after the 
loss of consciousness, atracurium 0.5 mg/Kg/IV 
administrated. Anesthesia maintained with propofol 100 
µg/Kg/IV/min and intermittent doses of atracurium 
administered with Controlled breathing. If necessary, 50 
micro fentanyl were administered. 
After surgery, another physician who was not the 
part of the anesthesia team and not informed of the drug 
group assignment recorded the occurrence of PONV and 
pain by asking the patients. 
 Pain score, after arrival in the recovery, at 1, 4, 8, 12 
and 24 h after surgery, using the VAS (where 0=no pain 
to 10=worst possible pain) at rest for pain assessment.  
When VAS scores were >3, for the patient 0.3-0.4 
mg of meperidine was given bolus. Calculated total 
blood volume of blood loss during surgery is collected 
in suction, and the number of blood gases was obtained. 
The occurrences of postoperative side effects such as 
PONV were recorded at follow-up intervals. 
All data were recorded in prepared checklists and 
were coded for statistical analysis. 
Results were reported as mean±standard deviation 
(SD) for quantitative variables and percentages for 
categorical variables. The groups were compared using 
the Student’s t-test and repeated measurement ANOVA 
for continuous variables and the Chi-square test (or 
Fisher’s exact test if required) for categorical variables. 
All the statistical analysis were performed using SPSS 
version 19 (SPSS Inc, Chicago, IL, USA) for 
Windows. P<0.05 were considered statistically 
significant.  
 
Results 
 
Table 1 shows a summary of the baseline 
characteristics of both groups. There was no significant 
difference between the groups regarding any of the 
studied parameters. Mean arterial blood pressure; heart 
rate values did not differ between the groups at any of 
the measured time intervals. 
The VAS pain scores were significantly lower in the 
gabapentin group compared with the oxycodone group 
at all measurements for 24 h (P=0.0001) (Figure 1). 
The mean amount of meperidine used in the 
oxycodone group (47.2±14.3 mg) was significantly 
more than in the gabapentin group (25±0 mg, P=0.0001) 
(Figure 2). 
The mean amount of bleeding loss in the oxycodone 
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group (415±50.8 mL) was significantly more than in the 
gabapentin group (333.4±38.09 mL, P=0.0001) (Figure 
3). 
In addition, none of the patients in the gabapentin 
group have PONV, and PONV were significantly more 
common in the oxycodone group compared with the 
gabapentin group (P=0.0001). 
 
 
Table 1. The demographic and clinical data of the study patients 
Variable Gabapentin(n=30) Oxycodone (n=30) P* 
Age  47.8±8.1 49.4±9.1 0.356 
Weight (Kg)  68.7±13.2 68.1±4.1 0.803 
Duration time of 
surgery (h)  
2.75±0.45 3±0.4 0.004 
Duration time of 
anesthesia (min)  
77±10 76±9 0.057 
ASA 
Class  
I 25 (50%) 22 (44%) 
0.216 
II 25 (50%) 28 (56%) 
* Student’s t-test, P<0.05 assumed meaningful 
 
 
 
Table 2. Mean VAS in different time after surgery between two groups 
Variable Gabapentin(n=30) Oxycodone (n=30) P* 
 Arrival 
time to 
recovery  
3.2±0.4 3.9±1.2 0.015 
6 (h) 4.7±0.9 4.9±1.06 0.884 
12 (h) 4.7±1.2 5.3±1.2 0.006 
24 (h) 2.9±0.6 3.7±1.3 0.001 
* Student’s t-test, P<0.05 assumed meaningful 
 
 
 
 
 
Figure 1. VAS scores of patients in different postoperative time 
between two groups (P=0.0001) 
 
 
 
 
 
 
 
 
Figure 2. Postoperative meperidine consumption in two groups 
(P=0.0001) 
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Figure 3. Intraoperative bleeding loss amount in two groups 
(P=0.0001) 
 
Discussion 
 
The present study showed that 900 mg gabapentin 
administered 1 h before surgery reduced pain and opioid 
consumption. Pain after surgery is due to both surgical 
stimulation and neurogenic factors.  
Several methods are used to reduce postoperative 
pain such as non-steroidal anti-inflammatory drugs 
(NSAIDs), opioids, pre-emptive medications and local 
anesthetics (13). 
Gabapentin is firstly used as an anticonvulsant drug, 
but recent studies have demonstrated that also has 
antihyperalgesic effects especially before surgery 
process (14).  
In animal studies have been shown that pre-operative 
treatment with gabapentin may prevent pain more 
effectively than when received after surgery (15).  
Probably, gabapentin mechanism through 
postsynaptic binding to the α2 and µ1 subunits of the 
voltage-dependent calcium channels of the dorsal horn 
neurons in the spinal cord, decreasing calcium entry into 
the nerve endings and inhibiting the release of 
neurotransmitters (16). 
However, different results exist regarding the effects 
of gabapentin on pain and opioid consumption. Turan et 
al. reported that 1200 mg gabapentin on pain and 
tramadol consumption after hysterectomy was reduced 
in the gabapentin group (2 .(  In another study by Durmus 
et al., demonstrated that 1200 mg gabapentin and 
gabapentin with acetaminophen were compared with 
placebo in hysterectomy patients were significantly 
decreased pain intensity and morphine requirement after 
surgery )17 .(  Some studies revealed like results (15,18). 
In contrast to the studies showing positive effect of 
gabapentin on pain and opioid requirement, some 
studies have reported no or low effects.  
Dierking et al. reported no difference in pain after 
hysterectomy between patients treated with 3000 mg 
gabapentin and placebo (19). 
Radhakrishnan et al., found pain level and opioid 
consumption after lumbar laminectomy and discectomy 
in patients receiving 800 mg gabapentin or placebo, no 
difference between groups (20). 
These findings are likely due to either difference in 
the time of opioid administration, or the fact that each 
patient in the test group was administered 25 mg/h, of 
morphine regardless of reported pain level. Also, local 
anesthetic which blunts the anti-hyperalgesic effects of 
gabapentin. In previous research has reported that 
gabapentin requires 1 h to 2 h to take effect. Also, the 
short duration of surgery is insufficient time for the drug 
to take effect. PONV observed commonly after 
anesthesia and surgery with an overall incidence of 25-
30%. It is one of the most common causes for poor 
patient satisfaction ratings in the postoperative period 
(21-23). In our study, a significant decrease in PONV 
was found in gabapentin group. Our clinical study on 
postoperative pain found that a pre-emptive 900 mg oral 
dose of gabapentin reduces the pain scores and 
meperidine requirement in the immediate period and 
also reduces nausea and vomiting in patients undergoing 
abdominal hysterectomy. 
Pain after abdominal hysterectomy can be 
multifactorial including incisional, dynamic pain and 
visceral pain, such as during straining, coughing, or 
mobilizing, like to any abdominal surgery. According to 
this study, we suggest that administration of pre-emptive 
gabapentin 900 mg for reducing postoperative pain and 
PONV after hysterectomy or any abdominal surgery. 
In summary, perioperative administration 900 mg of 
gabapentin decreases postoperative pain, PONV and the 
requirement for opioids in the post- operative period in 
patients who undergo abdominal hysterectomy. Also, 
significant side effects were not observed. 
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